Tidal Investments LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,154 shares of the company's stock, valued at approximately $419,000.
Other hedge funds also recently added to or reduced their stakes in the company. Barclays PLC boosted its stake in shares of Oscar Health by 217.5% during the 3rd quarter. Barclays PLC now owns 325,818 shares of the company's stock worth $6,911,000 after acquiring an additional 223,189 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Oscar Health by 24.2% in the 4th quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company's stock valued at $778,000 after buying an additional 11,282 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in Oscar Health by 28.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company's stock valued at $295,000 after buying an additional 4,838 shares in the last quarter. KBC Group NV lifted its stake in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares in the last quarter. Finally, GDS Wealth Management lifted its stake in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after buying an additional 324,798 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Stock Up 0.1%
OSCR stock traded up $0.02 during midday trading on Tuesday, hitting $14.28. The company's stock had a trading volume of 13,935,752 shares, compared to its average volume of 4,463,957. The firm has a market capitalization of $3.64 billion, a P/E ratio of -713.54 and a beta of 1.75. The firm has a 50-day simple moving average of $13.76 and a 200-day simple moving average of $14.58. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company's revenue for the quarter was up 42.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.62 EPS. As a group, equities analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on OSCR. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen raised shares of Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $18.50.
Check Out Our Latest Research Report on Oscar Health
Insider Transactions at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 24.39% of the company's stock.
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.